Revenue increase of 3.3% and an operating profit margin of 7.0% in 9M 2019 before restructuring costs
Performance highlights for the third quarter of 2019 and guidance:
Revenue increased by 4.1% in Q3 2019 compared to Q3 2018 driven by growth from international life sciences (by 95%), finance (by 20%), Danish life sciences (by 12%) and enterprise (by 6.7%) customers, while
With the technology, the partners will help companies automate their quality assurance so that the statutory processes support innovation.
Med teknologien vil partnerne hjælpe virksomheder med at automatisere deres kvalitetssikring, så de lovpligtige processer støtter op om innovation.
NNIT assumes responsibility for parts of the energy group’s central IT systems, which will be consolidated into the cloud to enable agile development and economies of scale.
NNIT overtager ansvaret for dele af energikoncernens centrale it-systemer, som lægges sammen i skyen for at muliggøre agil udvikling og udnytte stordriftsfordele.
Strong teamwork and a proven platform help companies scale and coordinate artificial intelligence solutions across their business.
Et stærkt hold og en velafprøvet platform hjælper virksomheder med at skalere og koordinere løsninger med kunstig intelligens på tværs af forretningen.
Resultatet i hovedtal for de første tre måneder af 2019:
Nettoomsætningen steg med 7,4 % understøttet af en stærk vækst fra internationale life sciences og enterprise kunder på henholdvis 73 % (27 % organisk) og 28 %. Novo Nordisk-koncernen steg med 1,1 % sammenlignet med 1. kvartal 2018 som var på et lavt niveau. Stigningen blev delvist modsvaret af et fald blandt offentlige kunder på 10 % og
Performance highlights for the first three months of 2019
Revenue increased by 7.4% driven by growth in the international life sciences and finance customer groups of 73% (organic 27%) and 28%, respectively, while the enterprise customer group increased by 5.9%. The Novo Nordisk Group increased by 1.1% compared to Q1 2018 which was at a low level. This was partly countered by a decli
Access to leading experts within life sciences IT expands NNIT’s portfolio of services to the life sciences industry.
NNIT udvider sine ydelser til life sciences-industrien med adgang til ledende eksperter.
Full year revenue growth of 5.5% and an operating profit margin of 10.2%
Performance highlights for full year 2018
Revenue from clients outside the Novo Nordisk Group increased by 13% driven by the international life sciences, public and enterprise customer groups all increasing double-digit
Due to a decline in revenue from the Novo Nordisk Group of 5.2% total revenue increased by 5.5
